Doctor-Patient Communication in Spanish

This study has been terminated.

First Received: September 14, 2005 Last Updated: January 13, 2006 History of Changes

Sponsored by:	University of California, San Francisco
Information provided by:	University of California, San Francisco
ClinicalTrials.gov Identifier:	NCT00187785

Purpose

Does use of a translator or use of less than perfect Spanish diminish provider-patient communication compared to a native speaker.

Condition	Intervention
Upper Respiratory Infection Hypertension Diabetes	Behavioral: Spanish speaker level

MedlinePlus related topics: High Blood Pressure

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Educational/Counseling/Training, Randomized, Open Label, Dose Comparison, Parallel Assignment, Efficacy Study
Official Title:	Doctor-Patient Communication in Spanish

Further study details as provided by University of California, San Francisco:

Primary Outcome Measures:

retention of medical information

Secondary Outcome Measures:

patient satisfaction

Estimated Enrollment:	100
Study Start Date:	September 2005
Estimated Study Completion Date:	December 2006

Detailed Description:

Spanish speaking drop-in patients will be consented then randomized to receive care by a native Spanish speaker, an English speaker using a translator, or an English speaker with intermediate Spanish skills using Spanish. After the visit, the researcher will enquire about patient satisfaction, when the next appointment is, whether medication has been changed, and what instructions their provider gave them. Each provider will do a similar questionnaire.

A blinded researcher will score a concordance of plans between provider and patient to see if there is a significant difference in retained information between the groups.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria: - Spanish speaker Exclusion Criteria: -

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00187785

Locations

United States, California
UMC Family Health Center
Fresno, California, United States, 93702

Sponsors and Collaborators

University of California, San Francisco

Investigators

Principal Investigator:

Roger B Mortimer, MD

Department of Family Practice

More Information

No publications provided

Study ID Numbers:	UMC200552
Study First Received:	September 14, 2005
Last Updated:	January 13, 2006
ClinicalTrials.gov Identifier:	NCT00187785 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by University of California, San Francisco:

Hispanic
communication

Study placed in the following topic categories:

Respiratory Tract Diseases
Respiratory Tract Infections
Vascular Diseases
Diabetes Mellitus
Hypertension

Additional relevant MeSH terms:

Respiratory Tract Diseases
Respiratory Tract Infections
Vascular Diseases

Cardiovascular Diseases
Infection
Hypertension

ClinicalTrials.gov processed this record on May 07, 2009